Nanoscope Therapeutics to Present at JP Morgan Healthcare Conference

Nanoscope Therapeutics Inc., focused on restoring vision through innovative gene therapies, announced that CEO Sulagna Bhattacharya will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at 4:00 p.m. PT in San Francisco.

The presentation will cover progress on the BLA submission for MCO-010, advancements in the AAV program for Stargardt macular degeneration, and plans for a first-in-human trial of a non-viral platform for geographic atrophy.

Learn more